Anti-vascular agent Combretastatin A-4-P modulates Hypoxia Inducible Factor-1 and gene expression

被引:0
|
作者
Gabi U Dachs
Andrew J Steele
Claudia Coralli
Chryso Kanthou
Andrew C Brooks
Sarah P Gunningham
Margaret J Currie
Ally I Watson
Bridget A Robinson
Gillian M Tozer
机构
[1] University of Otago,Angiogenesis Research Group, Department of Pathology, Christchurch School of Medicine and Health Sciences
[2] Mount Vernon Hospital,Tumour Microcirculation Group, Gray Cancer Institute
[3] University of Sheffield,Academic Unit of Surgical Oncology, Division of Clinical Sciences
来源
BMC Cancer | / 6卷
关键词
Electrophoretic Mobility Shift Assay; VEGF Expression; Human Dermal Microvascular Endothelial Cell; Combretastatin; SW1222 Colon Carcinoma Cell;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Anti-vascular agent Combretastatin A-4-P modulates Hypoxia Inducible Factor-1 and gene expression
    Dachs, Gabi U.
    Steele, Andrew J.
    Coralli, Claudia
    Kanthou, Chryso
    Brooks, Andrew C.
    Gunningham, Sarah P.
    Currie, Margaret J.
    Watson, Ally I.
    Robinson, Bridget A.
    Tozer, Gillian M.
    BMC CANCER, 2006, 6 (1)
  • [2] Effect of radiation and combretastatin A-4-P on cellular localisation of hypoxia inducible factor 1
    Dachs, GU
    Kanthou, C
    Tozer, GM
    22ND MEETING OF THE EUROPEAN SOCIETY FOR MICROCIRCULATION: MICROCIRCULATION AND VASCULAR BIOLOGY, 2002, : 19 - 23
  • [3] Chelation of cellular calcium modulates hypoxia-inducible gene expression through activation of hypoxia-inducible factor-1α
    Berchner-Pfannschmidt, U
    Petrat, F
    Doege, K
    Trinidad, B
    Freitag, P
    Metzen, E
    de Groot, H
    Fandrey, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (43) : 44976 - 44986
  • [4] Efficacy of the tumour vascular targeting agent combretastatin A-4-P at clinically relevant doses
    Tozer, GM
    Honess, DJ
    Wilson, J
    Hill, SA
    Hodgkiss, RJ
    Ameer-Beg, S
    Vojnovic, B
    Prise, VE
    22ND MEETING OF THE EUROPEAN SOCIETY FOR MICROCIRCULATION: MICROCIRCULATION AND VASCULAR BIOLOGY, 2002, : 43 - 47
  • [5] Inhibition of proliferative retinopathy by the anti-vascular agent combretastatin-A4
    Griggs, J
    Skepper, JN
    Smith, GA
    Brindle, KM
    Metcalfe, JC
    Hesketh, R
    AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (03): : 1097 - 1103
  • [6] Expression of Vascular Endothelial Growth Factor and Hypoxia Inducible Factor-1α in Cervical Neoplasia
    No, Jae Hong
    Jo, Hoenil
    Kim, Su-Hyeong
    Park, In-Ae
    Kang, Daehee
    Han, Seung-Su
    Kim, Jae Weon
    Park, Noh-Hyun
    Kang, Soon-Beorn
    Song, Yong-Sang
    NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS, 2009, 1171 : 105 - 110
  • [7] Expression of hypoxia inducible factor-1 and vascular endothelia growth factor in vocal polyps
    Fang, Rui
    Jiang, Jack J.
    Smith, Benjamin L.
    Wu, Daquan
    LARYNGOSCOPE, 2013, 123 (09): : 2184 - 2188
  • [8] Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells
    Merighi, Stefania
    Benini, Annalisa
    Mirandola, Prisco
    Gessi, Stefania
    Varani, Katia
    Leung, Edward
    Maclennan, Stephen
    Borea, Pier Andrea
    BIOCHEMICAL PHARMACOLOGY, 2006, 72 (01) : 19 - 31
  • [9] Mitophagy Protects the Retina Against Anti-Vascular Endothelial Growth Factor Therapy-Driven Hypoxia via Hypoxia-Inducible Factor-1α Signaling
    Sun, Yimeng
    Wen, Feng
    Yan, Chun
    Su, Lishi
    Luo, Jiawen
    Chi, Wei
    Zhang, Shaochong
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [10] Expression of hypoxia-inducible factor-1α and vascular endothelial growth factor in glioblastoma multiforme
    Sondergaard, KL
    Hilton, D
    Demaine, AG
    BRITISH JOURNAL OF CANCER, 1999, 81 (04) : 580 - 581